Announcements Trials
Browse Landscape

Status

Completed 3Unknown 2

Sponsor Class

OTHER 3

Study Type

Interventional 57Observational 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Seizures 1Lung Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Observational × Dexmedetomidine × Clear all
NCT05103735 2023-01-31

Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity

Azienda Sanitaria-Universitaria Integrata di Udine

Completed
170 enrolled

Seizures

NCT00839605 2016-10-04

Dex-One-Lung

University of Missouri-Columbia

Completed
25 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT01692210 2016-01-07

The Effect of Dexmedetomidine of the Immune System

M.D. Anderson Cancer Center

Completed
20 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡